Tasigna (nilotinib)

**Product type:** Human Prescription Drug

**Active ingredient:** NILOTINIB HYDROCHLORIDE MONOHYDRATE

**Strength:** 150 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** NDA (NDA022068)

**Pharmacologic class:** Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA]